23 hrs ago | Berkshire Eagle
A Peru woman accused of stealing powerful pain-control patches from a nursing home resident has pleaded guilty to larceny and assault charges. via Berkshire Eagle
Sunday May 11 | Pharmaceutical Online
BEMA Fentanyl Phase III Data Demonstrating Efficacy And Tolerability...
“Breakthrough cancer pain can be devastating to patients with cancer and their families. Patients suffering from breakthrough cancer pain need treatment options that provide effective pain relief and are easy to administer.”
BioDelivery Sciences International, Inc. and commercial partner Meda Pharmaceuticals will present today and tomorrow, data from Phase III clinical pivotal trials for BEMA Fentanyl, a potential treatment for ... via Pharmaceutical Online
Friday May 9 | CiteULike
Premedication with pregabalin 75 or 150 mg with ibuprofen to control...
Abstract BACKGROUND: /st> Multimodal pain management has been suggested to improve postoperative analgesia. via CiteULike
Wednesday May 7 | Med Ad News
Cephalon Conference Call Invitation
Cephalon, Inc. today announced plans to host an investor conference call at 5:30 p.m. EDT on May 6, 2008 to discuss the U.S. Food and Drug Administration advisory committee panel meeting held that day. via Med Ad News
Monday May 5 | Earth Times
Ym Biosciences Announces Presentations for Aerolef(TM) at American Pain Society Annual Meeting
The first poster presentation, entitled "A randomized controlled trial demonstrates the efficacy, safety and tolerability of Aerosolized free and Liposome-Encapsulated Fentanyl ) via pulmonary administration", ... via Earth Times
Friday May 2 | The Epoch Times
U.S. FDA Concerned Over Wider Cephalon Pain Drug Use
“We are concerned that the sponsor's request to expand the current indication for Fentora ... may greatly increase the prescribing of this product which may increase the availability of the product for diversion, abuse and misuse”
Approving Cephalon Inc's Fentora pain drug for patients without cancer could have "devastating effects," a U.S. Food and Drug Administration official said in documents released on Friday. via The Epoch Times
Friday Apr 18 | The West Virginia Record
this Just in: Monongalia County
April 10 Keisha Garner, personal representative of the Estate of Linda Burrell v. Mylan Inc., Mylan Pharmaceuticals Inc. via The West Virginia Record
Wednesday Apr 16 | Fool.com
Cephalon Convinces the Continent
On Monday, specialty pharma extraordinaire Cephalon announced that the European Union finally approved its fentanyl pain drug Fentora. via Fool.com
Monday Apr 14 | Philadelphia Business Journal
Cephalon cancer pain drug approved in European Union
The European Commission granted marketing authorization for a tablet formulation of Cephalon Inc. via Philadelphia Business Journal
Apr 5, 2008 | Reuters
Watson recalls single lot of fentanyl patches
Watson Pharmaceuticals has recalled one lot, or about 28,000 units, of its fentanyl pain patch after ingredient levels were found to have deviated from specifications, a company spokeswoman said on Friday. via Reuters